EW Healthcare Partners, L.P. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-08 5:28 pm Sale | 2023-12-04 | 13D | EYEPOINT PHARMACEUTICALS, INC. EYPT | EW Healthcare Partners, L.P. | 2,337,786 5.000% | -1,312,606 (-35.96%) | Filing |
| 2023-08-30 5:22 pm Sale | 2019-03-28 | 13D | EYEPOINT PHARMACEUTICALS, INC. EYPT | EW Healthcare Partners, L.P. | 3,650,392 10.400% | -540,004 (-12.89%) | Filing |